A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a retrospective observational study which follows on from CNA106030 (a study
evaluating whether prospective genetic screening for HLA-B*5701 can reduce the incidence of
hypersensitivity reactions to abacavir). This study aims to collect data on approximately 35
subjects who withdrew from CNA106030 when found to be HLA-B*5701 positive. HIV disease
management and adverse event data in these subjects, where the risk/benefit ratio of
treatment with abacavir may alter subsequent prescribing, will be collected